A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NP / nucleoprotein

[Related PubMed/MEDLINE]
Total Number of Papers: 1327
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NP  (>> Co-occurring Abbreviation)
Long Form:   nucleoprotein
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A self-calibrating electrochemical aptasensing platform: Correcting external interference errors for the reliable and stable detection of avian influenza viruses. 3DNRE, AIVs, MB
2020 Amino Acid Mutations A286V and T437M in the Nucleoprotein Attenuate H7N9 Viruses in Mice. ---
2020 Cellular mRNA export factor UAP56 recognizes nucleic acid binding site of influenza virus NP protein. NTE, vRNPs
2020 Detection of a Reassortant H9N2 Avian Influenza Virus with Intercontinental Gene Segments in a Resident Australian Chestnut Teal. ---
2020 Development of an Isavirus minigenome system to study the function of the pocket RNA-binding domain of the viral nucleoprotein (NP) in salmon cells. RNP
2020 Epidemiologic Survey of Avian Influenza Virus Infection in Shorebirds Captured in Hokkaido, Japan. AIVs, HA, NA, PA
2020 Genetic variations on 31 and 450 residues of influenza A nucleoprotein affect viral replication and translation. ---
2020 Heterologous viral protein interactions within licensed seasonal influenza virus vaccines. HA, NA
2020 Hexamer phasing governs transcription initiation in the 3'-leader of Ebola virus. EBOV, TSS
10  2020 Methionine enkephalin inhibits influenza A virus infection through upregulating antiviral state in RAW264.7 cells. MOR
11  2020 MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection. IAV, ts
12  2020 Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111. BSL-4, VLP
13  2020 The Ebola Virus Nucleoprotein Recruits the Nuclear RNA Export Factor NXF1 into Inclusion Bodies to Facilitate Viral Protein Expression. EBOV, NXF1
14  2020 The G Protein-Coupled Receptor FFAR2 Promotes Internalization during Influenza A Virus Entry. Cmp58, FFAR2, GPCR, IAV, SA, siRNA, vRNP
15  2020 Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells. HA, HPAI, IAV, LPAI
16  2019 Age-dependent pathogenesis of clade 2.3.4.4A H5N2 HPAIV in experimentally infected Broad Breasted White turkeys. AIV, dpi, HPAI
17  2019 Alteration of ssRNA Torsion and Water Influx Into ssRNA Pocket in K309A and S247A mutations. LV
18  2019 Alternative interaction sites in the influenza A virus nucleoprotein mediate viral escape from the importin-alpha7 mediated nuclear import pathway. ---
19  2019 Antiviral effects against influenza A virus infection by a short hairpin RNA targeting the non-coding terminal region of the viral nucleoprotein gene. IAV, MEFs, PR8, RNAi, shRNA, vRNA
20  2019 Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus. ATV, ROS
21  2019 Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph. ---
22  2019 Characterization and Phylodynamics of Reassortant H12Nx Viruses in Northern Eurasia. AIV, HA, NS
23  2019 Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells. IFN, IL, mPSCs
24  2019 Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines. APCs, GM-CSF, SAM
25  2019 Combinatorial mutagenesis of rapidly evolving residues yields super-restrictor antiviral proteins. IAV, THOV
26  2019 Complete genome sequence of a novel reassortant H3N3 avian influenza virus. AIV, HA, IAVs, NA, NS, PA, PB1, PB2
27  2019 Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules. HLA, RMSD
28  2019 Development of a recombinant NP protein based indirect ELISA for the detection of antibodies against Newcastle disease virus and differentiation of infected or recombinant vaccine immunized chickens. ND, NDV
29  2019 Development of Multispecies Recombinant Nucleoprotein-Based Indirect ELISA for High-Throughput Screening of Crimean-Congo Hemorrhagic Fever Virus-Specific Antibodies. CCHF, CCHFV, ELISA, iELISA
30  2019 Development of Replication Protein A-Conjugated Gold Nanoparticles for Highly Sensitive Detection of Disease Biomarkers. cTnI, LFIAs, POC
31  2019 Efficient ligand discovery from natural herbs by integrating virtual screening, affinity mass spectrometry and targeted metabolomics. MS
32  2019 Equine Mx1 Restricts Influenza A Virus Replication by Targeting at Distinct Site of its Nucleoprotein. eqMx1, huMxA, IAV, Mx
33  2019 Eurasian Avian-Like Swine Influenza A Viruses Escape Human MxA Restriction through Distinct Mutations in Their Nucleoprotein IAV
34  2019 Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. EBOV, EVs, GP
35  2019 Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus. EBOV, MA, PFU
36  2019 Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies. mAbs
37  2019 H5N8 avian influenza virus acquires enhanced pathogenicity after a single passage in chicken. HPAIVs
38  2019 HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection. GP, KIRs, LASV, NK
39  2019 Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription. EBOV, SMYD3
40  2019 Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein. AP-MS, Co-IP, EBOV, IF, PPIs, SIM
41  2019 Importance of tyrosine in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein for polymerase activity. hPIV-2
42  2019 Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats. M2e, PR8
43  2019 Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform. CTL, GAG, PapMV
44  2019 Influenza A Virus Utilizes Low-Affinity, High-Avidity Interactions with the Nuclear Import Machinery To Ensure Infection and Immune Evasion. IAV, KPNAs, NLS
45  2019 Inhibition of Influenza A Virus Replication by TRIM14 via Its Multifaceted Protein-Protein Interaction With NP. IAV, TRIM
46  2019 Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation. DI, IAV, IFNs, NEP, RIG-I, svRNA
47  2019 Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice. ---
48  2019 Loss of Fitness of Mexican H7N3 Highly Pathogenic Avian Influenza Virus in Mallards after Circulating in Chickens. AI, HA, HPAI
49  2019 Molecular Characterization of a Novel Avian Influenza A (H2N9) Strain Isolated from Wild Duck in Korea in 2018. HA, LPAI, NA, NS, PA
50  2019 MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein. ---
51  2019 Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. GP, SUDV, VP30
52  2019 Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses. HA, NA, ORF, PR8, WT
53  2019 MVA-NP+M1 vaccine activates mucosal M1-specific T cell immunity and tissue-resident memory T cells in human nasopharynx-associated lymphoid tissue. MNC, NALT, TRM
54  2019 Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection. ---
55  2019 Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export. ---
56  2019 Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity. EBOV, GP, WT
57  2019 Novel application of Influenza A virus-inoculated chorioallantoic membrane to characterize a NP-specific monoclonal antibody for immunohistochemistry assaying. AIV, CAM, IFA, IHC, mAbs, rNP, WB
58  2019 Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits. ---
59  2019 Novel protein microarray for the detection of avian influenza virus antibodies and simultaneous distinction of antibodies against H5 and H7 subtypes. AIV, ELISA, HI
60  2019 Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus. CTL, rAd
61  2019 OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes. IIVs
62  2019 Packaging of the Influenza Virus Genome Is Governed by a Plastic Network of RNA- and Nucleoprotein-Mediated Interactions. vRNPs
63  2019 Paratope Duality and Gullying are Among the Atypical Recognition Mechanisms Used by a Trio of Nanobodies to Differentiate Ebolavirus Nucleoproteins. sdAb
64  2019 Phosphorylation Status of Tyrosine 78 Residue Regulates the Nuclear Export and Ubiquitination of Influenza A Virus Nucleoprotein. IAV
65  2019 Pipetting-based immunoassay for point-of-care testing: Application for detection of the influenza A virus. LFIA, POCT
66  2019 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase. IAV, PARP1, RdRp
67  2019 Pterodontic acid isolated from Laggera pterodonta suppressed RIG-I/NF-KB/STAT1/Type I interferon and programmed death-ligand 1/2 activation induced by influenza A virus in vitro. HA, NA, NS, PA, PB1, PB2, RIG-I
68  2019 Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses. IAV, PA
69  2019 Quick electrochemical immunoassay for hantavirus detection based on biochar platform. Ab, BC, HCPS, YF
70  2019 RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference. MDCK, siRNA
71  2019 Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line. ---
72  2019 Single-Nucleotide Polymorphism Analysis to Select Conserved Regions for an Improved Real-Time Reverse Transcription-PCR Test Specific for Newcastle Disease Virus. LOD, NDV, RRT-PCR, SNP
73  2019 Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment. ---
74  2019 Sumoylation of nucleoprotein (NP) mediated by activation of NADPH oxidase complex is a consequence of oxidative cellular stress during infection by Infectious salmon anemia (ISA) virus necessary to viral progeny. ISA
75  2019 The Extended C-Terminal Region of Influenza C Virus Nucleoprotein Is Important for Nuclear Import and Ribonucleoprotein Activity. ICV, NLSs, NPC
76  2019 The Ntail region of nucleocapsid protein is associated with the pathogenicity of pigeon paramyxovirus type 1 in chickens. PPMV-1
77  2019 The structure of the nucleoprotein of Influenza D shows that all Orthomyxoviridae nucleoproteins have a similar NPCORE, with or without a NPTAIL for nuclear transport. NLS
78  2019 Toosendanin From Melia Fructus Suppresses Influenza A Virus Infection by Altering Nuclear Localization of Viral Polymerase PA Protein. HA, MF, NA, NS1, PA, TSN
79  2019 Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo. CPP, TP
80  2019 Unraveling the role of the MOV10 RNA helicase during influenza A virus infection. IAV, MOV10, NS
81  2019 Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge. ChAdOx1, HA, MVA
82  2019 Virus and host interactions critical for filoviral RNA synthesis as therapeutic targets. EBOV, PPIs, VP30, VP35
83  2018 A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge. CLDC, HA, IAV, RMs, vRNA, WIV
84  2018 A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen. GTV, HRTV, SFTSV, TBPVs
85  2018 Acetylation of lysine residues in the recombinant nucleoprotein and VP40 matrix protein of Zaire Ebolavirus by eukaryotic histone acetyltransferases. ---
86  2018 Aflatoxin B1 Promotes Influenza Replication and Increases Virus Related Lung Damage via Activation of TLR4 Signaling. AFB1, SIV
87  2018 Amino acid substitutions affecting aspartic acid 605 and valine 606 decrease the interaction strength between the influenza virus RNA polymerase PB2 '627' domain and the viral nucleoprotein. vRNP
88  2018 Amino acid substitutions in low pathogenic avian influenza virus strains isolated from wild birds in Korea. AI, HA
89  2018 Analysis of Reptarenavirus genomes indicates different selective forces acting on the S and L segments and recent expansion of common genotypes. GPC
90  2018 Assays to Assess Arenaviral Glycoprotein Function. GPC, LASV, PICV, S1P, SKI-1, SSP, VLP
91  2018 Assays to Demonstrate the Roles of Arenaviral Nucleoproteins (NPs) in Viral RNA Synthesis and in Suppressing Type I Interferon. GPC, IFN, LASV, MG, NPs, PICV
92  2018 Assays to Measure the Activity of Influenza Virus Polymerase. cRNAs, RdRp, vRNA
93  2018 Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein. SAR
94  2018 Broad-spectrum antiviral functions of duck interferon-induced protein with tetratricopeptide repeats (AvIFIT). AvIFIT, IFITs
95  2018 CDC25B promotes influenza A virus replication by regulating the phosphorylation of nucleoprotein. Cdc25B, IAV
96  2018 Conserved methionine 165 of matrix protein contributes to the nuclear import and is essential for influenza A virus replication. CLUH, CRM1
97  2018 Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens. IIVs, LAIVs
98  2018 DDX3 suppresses type I interferons and favors viral replication during Arenavirus infection. HF
99  2018 Development and Characterization of Monoclonal Antibodies against Nucleoprotein for Diagnosis of Influenza A Virus. H1N1, mAbs
100  2018 Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G. ELISA, IFA